<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2023-68-6-94-98</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1911</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Маски иммунодефицита: сложный диагностический случай синдрома Ниймеген</article-title><trans-title-group xml:lang="en"><trans-title>Immunodeficiency masks: a complex diagnostic case of Nijmegen breakage syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0740-1718</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мизерницкий</surname><given-names>Ю. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Mizernitskiy</surname><given-names>Y. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мизерницкий Юрий Леонидович — д.м.н., проф., зав. отделом хронических воспалительных и аллергических болезней легких</p><p>127412, Москва, ул. Талдомская, 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">yulmiz@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1963-4313</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зорина</surname><given-names>И. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Zorina</surname><given-names>I. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зорина Ирина Евгеньевна — врач отделения пульмонологии</p><p>127412, Москва, ул. Талдомская, 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8612-2126</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рынгаченко</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryngachenko</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рынгаченко Елизавета Сергеевна — мл. науч. сотр. отдела хронических воспалительных и аллергических болезней легких, врач-педиатр отделения пульмонологии</p><p>127412, Москва, ул. Талдомская, 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-5811-7710</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьмина</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmina</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузьмина Тамара Николаевна — врач-ординатор</p><p>127412, Москва, ул. Талдомская, 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9083-4783</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дерипапа</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Deripapa</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дерипапа Елена Васильевна — к.м.н., врач аллерголог-иммунолог, заведующая отделом оптимизации лечения иммунодефицитов</p><p>117198 Москва, ул. Саморы Машела, д. 1</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9857-4456</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Родина</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rodina</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Родина Юлия Александровна — к.м.н., зав. отделением иммунологии, ст. науч. сотр. отдела оптимизации лечения иммунодефицитов</p><p>117198 Москва, ул. Саморы Машела, д. 1</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3113-4939</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербина</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherbina</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щербина Анна Юрьевна –д.м.н., проф. РАН, зам. дир. Института гематологии, иммунологии и клеточных технологий</p><p>117198 Москва, ул. Саморы Машела, д. 1</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ОСП «Научно-исследовательский клинический институт педиатрии и детской хирургии им. академика Ю.Е. Вельтищева» (Институт Вельтищева) ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rogachev National Medical and Research Center for Pediatric Hematology, Oncology and Immunology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>13</day><month>01</month><year>2024</year></pub-date><volume>68</volume><issue>6</issue><fpage>94</fpage><lpage>98</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1911">https://www.ped-perinatology.ru/jour/article/view/1911</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Демонстрация важности мультидисциплинарного подхода в ранней верификации первичного иммунодефицитного состояния — синдрома Ниймеген.</p><p>Девочка поступила с жалобами на ежедневный продуктивный кашель, стойкое затруднение носового дыхания, слизистогнойное отделяемое, рецидивирующие инфекции дыхательных путей в течение 3 лет. С 2 лет болела затяжными рецидивирующими респираторными инфекциями, неоднократно получала стационарное лечение, системную антибактериальную терапию с недостаточным эффектом в виде сохранения жалоб. При компьютерной томографии органов грудной клетки выявлены единичные ателектазы, участки матового стекла. По месту жительства исключали иммунодефицитные состояния. При осмотре обнаружены фенотипические особенности по типу «птичьего» лица: скошенный лоб, выступающая вперед средняя часть лица, клювообразный нос, большие уши. Физическое развитие низкое: массо-ростовые показатели менее 3-го перцентиля. Из носовых ходов слизисто-гнойное отделяемое, продуктивный кашель. Аускультативно влажные хрипы по всем легочным полям. По остальным органам и системам без особенностей. При обследовании: глубокая Т-клеточная лимфопения, по данным компьютерной томографии признаки пансинусита, двустороннего отита; пневмофиброзные изменения поствоспалительного характера. По результатам спирометрии — смешанные нарушения. По результатам иммунологического и генетического дообследования верифицировано иммунодефицитное состояние — синдром Ниймеген, начата постоянная противовоспалительная, антибактериальная и противогрибковая терапия, заместительное введение иммуноглобулина.</p></sec><sec><title>Заключение</title><p>Заключение. В представленном клиническом наблюдении отражены особенности течения синдрома Ниймеген. Этот пример демонстрирует диагностическую сложность в верификации диагноза и показывает большую роль мультидисциплинарного подхода для начала соответствующей терапии, которая влияет на тяжесть течения заболевания и качество жизни больного.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose. The purpose of the study is to show the importance of a multidisciplinary approach in the early verification of the primary immunodeficiency — Nijmegen breakage syndrome. A girl was admitted with complaints of daily productive cough, persistent obstruction of nasal breathing, mucopurulent discharge, recurrent respiratory tract infections for three years. From the age of 2, she suffered from protracted recurrent respiratory infections, repeatedly received inpatient treatment with systemic antibiotic therapy with insufficient effect in the form of maintaining complaints. When examining according to CT scan of the chest — single atelectasis, ground glass areas. Immunodeficiency states were excluded at the place of residence. On examination: phenotypic features of the type of «bird-like» face — sloping forehead, middle part of the face protruding forward, beak-shaped nose, large ears. Physical development is low: weight and height indicators are less than the 3rd percentile. From the nasal passages mucopurulent discharge, productive cough. Auscultatory — moist rales in all lung fields. For other organs and systems — without features. On examination: deep T-cell lymphopenia, according to CT scan signs of pansinusitis, bilateral otitis media; post-inflammatory pneumofibrotic changes. According to the results ofspirometry — mixed lesions. According to the results of immunological and genetic additional examination, the immunodeficiency state — Nijmegen breakage syndrome was verified, constant anti-inflammatory, antibacterial and antifungal, immunoglobulin replacement therapy was initiated.</p></sec><sec><title>Conclusion</title><p>Conclusion. The presented clinical observation reflects the features of the course of the Nijmegen breakage syndrome. This example demonstrates the diagnostic complexity in verifying the diagnosis and shows the great importance of a multidisciplinary approach for the timely initiation of appropriate therapy, which, in turn, affects the severity of the disease and quality of life.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>синдром Ниймеген</kwd><kwd>первичный иммунодефицит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>Nijmegen breakage syndrome</kwd><kwd>primary immunodeficiency</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hasbaoui B.E., Elyajouri A., Abilkassem R., Agadr A. Nijmegen breakage syndrome: case report and review of literature. Pan African Med J 2020; 35: 85. DOI: 10.11604/pamj.2020.35.85.14746</mixed-citation><mixed-citation xml:lang="en">Hasbaoui B.E., Elyajouri A., Abilkassem R., Agadr A. Nijmegen breakage syndrome: case report and review of literature. Pan African Med J 2020; 35: 85. DOI: 10.11604/pamj.2020.35.85.14746</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kondratenko I., Paschenko O., Polyakov A., Bologov A. Nijmegen breakage syndrome. Advanc Exper Med Biol 2007; 601: 61–67. DOI: 10.1007/978–0–387–72005–0_6</mixed-citation><mixed-citation xml:lang="en">Kondratenko I., Paschenko O., Polyakov A., Bologov A. Nijmegen breakage syndrome. Advanc Exper Med Biol 2007; 601: 61–67. DOI: 10.1007/978–0–387–72005–0_6</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor A.M.R., Rothblum-Oviatt C., Ellis N.A., Hickson I.D., Meyer S, Crawford T.O. et al. Chromosome instability syndromes. Nature Rev Dis Prim 2019; 5(1): 64. DOI: 10.1038s41572–019–0113–0</mixed-citation><mixed-citation xml:lang="en">Taylor A.M.R., Rothblum-Oviatt C., Ellis N.A., Hickson I.D., Meyer S, Crawford T.O. et al. Chromosome instability syndromes. Nature Rev Dis Prim 2019; 5(1): 64. DOI: 10.1038s41572–019–0113–0</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Maciejczyk M., Mikoluc B., Pietrucha B., Heropolitanska-Pliszka E., Pac M., Motkowski R. et al. Oxidative stress, mitochondrial abnormalities and antioxidant defense in Ataxia-telangiectasia, Bloom syndrome and Nijmegen breakage syndrome. Redox Biol 2017; 11: 375–383. DOI: 10.1016/j.redox.2016.12.030</mixed-citation><mixed-citation xml:lang="en">Maciejczyk M., Mikoluc B., Pietrucha B., Heropolitanska-Pliszka E., Pac M., Motkowski R. et al. Oxidative stress, mitochondrial abnormalities and antioxidant defense in Ataxia-telangiectasia, Bloom syndrome and Nijmegen breakage syndrome. Redox Biol 2017; 11: 375–383. DOI: 10.1016/j.redox.2016.12.030</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pastorczak A., Szczepanski T., Mlynarski W.; International Berlin-Frankfurt-Munster (I-BFM) ALL host genetic variation working group. Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome. Eur J Med Genet 2016; 59(3):126–132. DOI: 10.1016/j.ejmg.2016.01.007</mixed-citation><mixed-citation xml:lang="en">Pastorczak A., Szczepanski T., Mlynarski W.; International Berlin-Frankfurt-Munster (I-BFM) ALL host genetic variation working group. Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome. Eur J Med Genet 2016; 59(3):126–132. DOI: 10.1016/j.ejmg.2016.01.007</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мухина А.А., Кузьменко Н.Б., Родина Ю.А., Хорева А.Л., Моисеева А.А., Швец О.А. и др. Эпидемиология первичных иммунодефицитов в Российской Федерации. Педиатрия им. Г.Н. Сперанского 2020; 99(2): 16–32.</mixed-citation><mixed-citation xml:lang="en">Mukhina A.A., Kuzmenko N.B., Rodina Yu.A., Khoreva A.L., Moiseeva A.A., Shvec O.A. et al. Epidemiology of primary immunodeficiency in the Russian Federation. Pediatriya im. G.N. Speranskogo 2020; 99(2): 16–32. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Каган М.Ю., Шулакова Н.С., Гумирова Р.А., Злодеева Е.А., Резник Н.В. Синдром Ниймеген (клиническое наблюдение). Педиатрическая фармакология 2012; 9(3): 102–105.</mixed-citation><mixed-citation xml:lang="en">Kagan M.Yu., Shulakova N.S., Gumirova R.A., Zlodeeva E.A., Reznik N.V. Nijmegen syndrome (clinical observation). Pediatricheskaya farmakologiya 2012; 9(3): 102–105. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Дерипапа Е.В., Родина Ю.А., Лаберко А.Л., Балашов Д.Н., Мякова Н.В., Зимин С.Б. Синдром Ниймеген у детей: клинико-лабораторная характеристика и оценка эффективности различных видов терапии. Педиатрия 2018; 97(4): 116–124.</mixed-citation><mixed-citation xml:lang="en">Deripapa E.V., Rodina Yu.A., Laberko A.L., Balashov D.N., Myakova N.V., Zimin S.B. Nijmegen syndrome in children: clinical and laboratory characteristics and evaluation of the effectiveness of various types of therapy. Pediatriya 2018; 97(4): 116–124. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Marczak H., Heropolitańska-Pliszka E., Langfort R., Roik D., Grzela K. Nijmegen Breakage Syndrome Complicated With Primary Pulmonary Granulomas. Pediatrics 2018; 142(4): e20180122. DOI: 10.1542/peds.2018–0122</mixed-citation><mixed-citation xml:lang="en">Marczak H., Heropolitańska-Pliszka E., Langfort R., Roik D., Grzela K. Nijmegen Breakage Syndrome Complicated With Primary Pulmonary Granulomas. Pediatrics 2018; 142(4): e20180122. DOI: 10.1542/peds.2018–0122</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Кондратенко И.В., Пащенко О.Е., Бологов А.А. Поражение легких при первичных иммунодефицитных состояниях. Под ред. Н.Н. Розиновой, Ю.Л. Мизерницкого. Орфанные заболевания легких у детей. М: Медпрактика-М, 2015: 170–186.</mixed-citation><mixed-citation xml:lang="en">Kondratenko I.V., Pashchenko O.E., Bologov A.A. Lung damage in primary immuno-deficiency conditions. In: Orphan lung diseases in children Ed. N.N. Rozinova, Y.L. Mizernitskiy. M: Medpraktika-M, 2015: 170–186. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Varon R., Demuth I., Chrzanowska K.H. Nijmegen Breakage Syndrome. https://www.ncbi.nlm.nih.gov/books/NBK1176</mixed-citation><mixed-citation xml:lang="en">Varon R., Demuth I., Chrzanowska K.H. Nijmegen Breakage Syndrome. https://www.ncbi.nlm.nih.gov/books/NBK1176</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Новак А.А., Мизерницкий Ю.Л. Первичная цилиарная дискинезия: состояние проблемы и перспективы. Медицинский совет 2021; 1: 276–285. DOI: 10.21518/2079–701X-2021–1–276–285</mixed-citation><mixed-citation xml:lang="en">Novak A.A., Mizernitskiy Yu.L. Primary ciliary dyskinesia: the state of the problem and prospects. Meditsinskii sovet 2021; 1: 276–285. (in Russ.) DOI: 10.21518/2079–701X-2021–1–276–285</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Filipiuk A., Kozakiewicz A., Kośmider K., Lejman M., Zawitkowska J. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies. Ann Agric Environ Med 2022; 29(2): 207–214. DOI: 10.26444/aaem/143541</mixed-citation><mixed-citation xml:lang="en">Filipiuk A., Kozakiewicz A., Kośmider K., Lejman M., Zawitkowska J. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies. Ann Agric Environ Med 2022; 29(2): 207–214. DOI: 10.26444/aaem/143541</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chrzanowska K.H., Gregorek H., Dembowska-Bagińska B., Kalina M.A, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 2012; 7: 13. DOI: 10.1186/1750–1172–7–13</mixed-citation><mixed-citation xml:lang="en">Chrzanowska K.H., Gregorek H., Dembowska-Bagińska B., Kalina M.A, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 2012; 7: 13. DOI: 10.1186/1750–1172–7–13</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dembowska-Baginska B., Perek D., Brozyna A., Wakulinska A., Olczak-Kowalczyk D., Gladkowska-Dura M. et al. Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS). Pediatr Blood Cancer 2009; 52(2): 186–190. DOI: 10.1002/pbc.21789</mixed-citation><mixed-citation xml:lang="en">Dembowska-Baginska B., Perek D., Brozyna A., Wakulinska A., Olczak-Kowalczyk D., Gladkowska-Dura M. et al. Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS). Pediatr Blood Cancer 2009; 52(2): 186–190. DOI: 10.1002/pbc.21789</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Batiuk E., Bassett M., Hakar M., Lin H.C., Hunter A.K. A rare case of primary gastric Hodgkin lymphoma in an adolescent with Nijmegen breakage syndrome. BMC Pediatrics 2023; 23: 189. DOI: 10.1186/s12887–023–03929</mixed-citation><mixed-citation xml:lang="en">Batiuk E., Bassett M., Hakar M., Lin H.C., Hunter A.K. A rare case of primary gastric Hodgkin lymphoma in an adolescent with Nijmegen breakage syndrome. BMC Pediatrics 2023; 23: 189. DOI: 10.1186/s12887–023–03929</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
